13 results match your criteria: "Saint Vincent's Comprehensive Cancer Center[Affiliation]"
Clin Nucl Med
January 2009
Nuclear Medicine Service, Saint Vincent's Comprehensive Cancer Center, New York, New York, USA.
A 37-year-old man with multiple myeloma in remission underwent routine fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) study for disease restaging. Both FDG-PET and CT images showed focal abnormalities in the region of the T6 vertebra, but the fused images that are routinely provided with PET/CT could precisely localize the FDG active lesion to a soft tissue focus in the epidural space, away from a lytic nonactive vertebral body lesion despite their close proximity. The PET/CT scan identified a few other metabolically active osseous lesions out of many lytic bony changes throughout the skeleton.
View Article and Find Full Text PDFJ Hematol Oncol
July 2008
Saint Vincent's Comprehensive Cancer Center, New York, NY, USA.
Purpose: In a departure from conventional strategies to improve treatment outcome for myeloid malignancies, we report the isolation of leukemia-specific peptides using a phage display library screened with freshly obtained human myeloid leukemia cells.
Results: A phage display library was screened by 5 rounds of biopanning with freshly isolated human AML cells. Individual colonies were randomly picked and after purification, biologic activity (growth and differentiation) on fresh AML cells was profiled.
Gastrointest Cancer Res
March 2007
Lynn Wood Neag Distinguished Professor of GI Oncology, Saint Vincent's Comprehensive Cancer Center, New York, NY, Chief Medical Officer, Aptium Oncology Inc., Los Angeles, CA.
Clin Adv Hematol Oncol
May 2006
Multiple Myeloma Service and Bone Marrow and Blood Stem Cell Transplantation Center, Saint Vincent's Comprehensive Cancer Center, New York City, NY, and New York Medical College, USA.
Oncology (Williston Park)
October 2005
Saint Vincent's Comprehensive Cancer Center, Department of Psychiatry, and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
The number of older adults in the general population continues to grow. As their numbers rise, the elderly and the management of their medical problems must be of increasing concern for health-care professionals. Within this older population, cancer is a leading cause of morbidity and mortality.
View Article and Find Full Text PDFBreast J
December 2005
Nuclear Medicine, Surgical Oncology and Medical Oncology Services, Saint Vincent's Comprehensive Cancer Center, Saint Vincent's Catholic Medical Center, and New York Medical College, New York, New York 10011, USA.
The diagnostic power of an integrated positron emission tomography/computed tomography (PET/CT) system for whole-body 2-fluoro-2-deoxy-d-glucose (FDG) imaging is clearly demonstrated in this case report. The precise anatomic localization of FDG uptake with CT in a PET/CT scan of a patient with known breast carcinoma helped identify a contralateral breast tumor with axillary lymph node metastasis despite the presence of extensive physiologic brown fat FDG uptake. Accordingly, the patient received appropriate surgical management and pathologic confirmation of the disease.
View Article and Find Full Text PDFJ Surg Oncol
June 2005
Saint Vincent's Comprehensive Cancer Center, New York, New York 10011, USA.
The curative management of gastric adenocarcinoma depends upon complete resection of the primary tumor. In patients with lymph node metastases in the resected specimen, the relapse and death rates from recurrent cancer are at least 70%-80%. There is continued debate over whether more extensive lymph node dissection (D2) improves survival when compared to less extensive operations.
View Article and Find Full Text PDFSemin Oncol
August 2004
Gastrointestinal Oncology Service, Saint Vincent's Comprehensive Cancer Center, New York, NY 10011, USA.
The curative management of gastric adenocarcinoma depends upon complete resection of the primary tumor. In patients with lymph node metastases in the resected specimen, the relapse and death rates from recurrent cancer are at least 70% to 80%. There is continued debate over whether more extensive lymph node dissection (D2) improves survival when compared to less extensive operations.
View Article and Find Full Text PDFBr J Haematol
November 2002
Myeloma and Transplantation Program, Saint Vincent's Comprehensive Cancer Center, New York, NY 10011, USA.
Five patients receiving increased dose or frequency of pamidronate beyond the recommended dose (90 mg/monthly) exhibited nephrotic proteinuria (range 3.96-24 g/24 h). On dose reduction or discontinuation, three of these patients showed decreased proteinuria to normal levels (< 1 g/24 h), and proteinuria decreased to 4.
View Article and Find Full Text PDFBioDrugs
February 2003
Myeloma and Transplant Service, Saint Vincent's Comprehensive Cancer Center, New York, New York, USA.
Waldenström's macroglobulinaemia is a rare B-cell malignancy. It is prevalent in the sixth and seventh decades, the median age at diagnosis being 63 years. Conventional treatment has involved alkylator therapy, especially chlorambucil given daily at a low dose or intermittently at a higher dose.
View Article and Find Full Text PDFSemin Oncol
December 2001
Saint Vincent's Comprehensive Cancer Center, 325 W 15th St., New York, NY 10011, USA.
Three cases of multiple myeloma treated with thalidomide are presented which highlight therapeutic dilemmas presented by therapy with this new agent. The difficulty of stem cell collection during thalidomide therapy is illustrated. The question of continuation of thalidomide after attainment of a plateau or remission is discussed and the management of neuropathy considered.
View Article and Find Full Text PDFAm J Med
March 2001
Saint Vincent's Comprehensive Cancer Center, Saint Vincent's Hospital and Medical Center, 153 West 11th Street, New York, NY 10011, USA.
Semin Radiat Oncol
April 1999
Department of Radiation Oncology, Saint Vincent's Comprehensive Cancer Center, New York, NY 10011, USA.
Neovascular age-related macular degeneration is the most common cause of severe irreversible blindness in the Western world in people older than age 50. Laser photocoagulation is the only proven treatment for this disease; however, fewer than 20% of patients are eligible for this treatment because the majority of choroidal neovascularization membranes are not visible by ophthalmoscopy or angiography. In addition, many patients elect not to undergo this treatment because laser treatment of subfoveal neovascular membranes results in immediate and permanent central visual loss.
View Article and Find Full Text PDF